In addition, just prior to submission of our paper, CCR2 expression by murine breast cancer cells was shown to support immune evasion by inhibiting dendritic cell infiltration and maturation, suppressing cytotoxic T cell activity, decreasing MHC class I expression and upregulating PD-L1 expression [44]. The gene discussed is CCR2; the disease is breast carcinoma.